Dr. Michael Mann is a cardiothoracic surgeon with particular interests in coronary bypass surgery, valve disease, aortic reconstruction, surgery for heart failure and thoracic cancer.
Mann's research interests include developing molecular therapies – treatments that target specific cells involved in disease – for disorders of the heart and lungs. While on the faculty at Harvard Medical School, he designed and directed the first clinical program for genetic manipulation during bypass surgery.
Mann earned his medical degree at the Stanford University School of Medicine. He completed a residency at Stanford Medicine and Brigham and Women's Hospital in Boston, followed by a fellowship at UCSF.